Zullo Investment Group »

Brainstorm Cell Therapeutics shares owned by Zullo Investment Group

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Zullo Investment Group from 13F filings

Historical chart of Zullo Investment Group investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Zullo Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Zullo Investment Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.4k 16k 0.27